相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Senolytic Drugs: Reducing Senescent Cell Viability to Extend Health Span
Paul D. Robbins et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 61, 2021 (2021)
Interleukin-8: A chemokine at the intersection of cancer plasticity, angiogenesis, and immune suppression
Kristen Fousek et al.
PHARMACOLOGY & THERAPEUTICS (2021)
Cellular senescence in ageing: from mechanisms to therapeutic opportunities
Raffaella Di Micco et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2021)
Senolysis by glutaminolysis inhibition ameliorates various age-associated disorders
Yoshikazu Johmura et al.
SCIENCE (2021)
Chemotherapy Induces Senescence-Like Resilient Cells Capable of Initiating AML Recurrence
Cihangir Duy et al.
CANCER DISCOVERY (2021)
Senolytic Targeting of Bcl-2 Anti-Apoptotic Family Increases Cell Death in Irradiated Sarcoma Cells
Julie Lafontaine et al.
CANCERS (2021)
Doxorubicin-induced senescence promotes stemness and tumorigenicity in EpCAM-/CD133-nonstem cell population in hepatocellular carcinoma cell line, HuH-7
Mustafa Karabicici et al.
MOLECULAR ONCOLOGY (2021)
Cancer Response to Therapy-Induced Senescence: A Matter of Dose and Timing
Maria Patrizia Mongiardi et al.
CANCERS (2021)
Senolytics for Cancer Therapy: Is All that Glitters Really Gold?
Valerie J. Carpenter et al.
CANCERS (2021)
CCL5 of glioma-associated microglia/macrophages regulates glioma migration and invasion via calcium-dependent matrix metalloproteinase 2
Caren Yu-Ju Wu et al.
NEURO-ONCOLOGY (2020)
NAMPT Inhibition Suppresses Cancer Stem-like Cells Associated with Therapy-Induced Senescence in Ovarian Cancer
Timothy Nacarelli et al.
CANCER RESEARCH (2020)
Therapy-Induced Senescence Drives Bone Loss
Zhangting Yao et al.
CANCER RESEARCH (2020)
Autophagy and autophagy-related proteins in cancer
Xiaohua Li et al.
MOLECULAR CANCER (2020)
Galacto-conjugation of Navitoclax as an efficient strategy to increase senolytic specificity and reduce platelet toxicity
Estela Gonzalez-Gualda et al.
AGING CELL (2020)
Senescent Stromal Cells Promote Cancer Resistance through SIRT1 Loss-Potentiated Overproduction of Small Extracellular Vesicles
Liu Han et al.
CANCER RESEARCH (2020)
Senescence-Induced Vascular Remodeling Creates Therapeutic Vulnerabilities in Pancreas Cancer
Marcus Ruscetti et al.
CELL (2020)
BH3 mimetics selectively eliminate chemotherapy-induced senescent cells and improve response inTP53wild-type breast cancer
Ashkan Shahbandi et al.
CELL DEATH AND DIFFERENTIATION (2020)
Senescent T cells within suppressive tumor microenvironments: emerging target for tumor immunotherapy
Xia Liu et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Senescent Cells: Emerging Targets for Human Aging and Age-Related Diseases
Shuling Song et al.
TRENDS IN BIOCHEMICAL SCIENCES (2020)
Using proteolysis-targeting chimera technology to reduce navitoclax platelet toxicity and improve its senolytic activity
Yonghan He et al.
NATURE COMMUNICATIONS (2020)
A BET family protein degrader provokes senolysis by targeting NHEJ and autophagy in senescent cells
Masahiro Wakita et al.
NATURE COMMUNICATIONS (2020)
The Senolytic Drug Navitoclax (ABT-263) Causes Trabecular Bone Loss and Impaired Osteoprogenitor Function in Aged Mice
Anuj K. Sharma et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Senescence-Associated Pro-inflammatory Cytokines and Tumor Cell Plasticity
Jean Paul Vernot
FRONTIERS IN MOLECULAR BIOSCIENCES (2020)
Preclinical antitumor efficacy of senescence -inducing chemotherapy combined with a nanoSenolytic
Irene Galiana et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Convergence of therapy-induced senescence (TIS) and EMT in multistep carcinogenesis: current opinions and emerging perspectives
Mir Mohd Faheem et al.
CELL DEATH DISCOVERY (2020)
Senolytic drugs: from discovery to translation
J. L. Kirkland et al.
JOURNAL OF INTERNAL MEDICINE (2020)
Endothelial cells under therapy-induced senescence secrete CXCL11, which increases aggressiveness of breast cancer cells
Hyun Jung Hwang et al.
CANCER LETTERS (2020)
Senolytic CAR T cells reverse senescence-associated pathologies
Corina Amor et al.
NATURE (2020)
Improved Autophagic Flux in Escapers from Doxorubicin-Induced Senescence/Polyploidy of Breast Cancer Cells
Agnieszka Bojko et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Senescence and the SASP: many therapeutic avenues
Jodie Birch et al.
GENES & DEVELOPMENT (2020)
Senescent Cells in Cancer Therapy: Friends or Foes?
Boshi Wang et al.
TRENDS IN CANCER (2020)
Selective elimination of senescent cells by mitochondrial targeting is regulated by ANT2
Sona Hubackova et al.
CELL DEATH AND DIFFERENTIATION (2019)
Tumor Cell Escape from Therapy-Induced Senescence as a Model of Disease Recurrence after Dormancy
Tareq Saleh et al.
CANCER RESEARCH (2019)
Targeting Tumor Microenvironment for Cancer Therapy
Catarina Roma-Rodrigues et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
CXCL5 induces tumor angiogenesis via enhancing the expression of FOXD1 mediated by the AKT/NF-κB pathway in colorectal cancer
Chun Chen et al.
CELL DEATH & DISEASE (2019)
Senolytic therapy alleviates Aβ-associated oligodendrocyte progenitor cell senescence and cognitive deficits in an Alzheimer's disease model
Peisu Zhang et al.
NATURE NEUROSCIENCE (2019)
Senescent cell clearance by the immune system: Emerging therapeutic opportunities
Larissa G.P. Langhi Prata et al.
SEMINARS IN IMMUNOLOGY (2019)
Cellular Senescence and the Immune System in Cancer
Luis I. Prieto et al.
GERONTOLOGY (2019)
Exploiting interconnected synthetic lethal interactions between PARP inhibition and cancer cell reversible senescence
Hubert Fleury et al.
NATURE COMMUNICATIONS (2019)
Senescent cells evade immune clearance via HLA-E-mediated NK and CD8+ T cell inhibition
Branca I. Pereira et al.
NATURE COMMUNICATIONS (2019)
Targeting amphiregulin (AREG) derived from senescent stromal cells diminishes cancer resistance and averts programmed cell death 1 ligand (PD-L1)-mediated immunosuppression
Qixia Xu et al.
AGING CELL (2019)
SILAC Analysis Reveals Increased Secretion of Hemostasis-Related Factors by Senescent Cells
Christopher D. Wiley et al.
CELL REPORTS (2019)
Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease
LaTonya J. Hickson et al.
EBIOMEDICINE (2019)
Targeting normal and cancer senescent cells as a strategy of senotherapy
Ewa Sikora et al.
AGEING RESEARCH REVIEWS (2019)
Cellular Senescence: Defining a Path Forward
Vassilis Gorgoulis et al.
CELL (2019)
Current overview on the clinical update of Bcl-2 anti-apoptotic inhibitors for cancer therapy
Vasanti Suvarna et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2019)
Inducing and exploiting vulnerabilities for the treatment of liver cancer
Cun Wang et al.
NATURE (2019)
Tumor cell escape from therapy-induced senescence
Tareq Saleh et al.
BIOCHEMICAL PHARMACOLOGY (2019)
Targeting BCL-xL improves the efficacy of bromodomain and extra-terminal protein inhibitors in triple-negative breast cancer by eliciting the death of senescent cells
Sylvia S. Gayle et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer
Anushka Dongre et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)
Targeting Cancer Cell Dormancy
Ariadna Recasens et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2019)
Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study
Jamie N. Justice et al.
EBIOMEDICINE (2019)
Targeting senescent cells alleviates obesity-induced metabolic dysfunction
Allyson K. Palmer et al.
AGING CELL (2019)
Cardiac glycosides are broad-spectrum senolytics
Ana Guerrero et al.
NATURE METABOLISM (2019)
Paeonol attenuates aging MRC-5 cells and inhibits epithelial-mesenchymal transition of premalignant HaCaT cells induced by aging MRC-5 cell-conditioned medium
Lihua Yang et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2018)
Senescence-associated reprogramming promotes cancer stemness
Maja Milanovic et al.
NATURE (2018)
Cellular senescence: Immunosurveillance and future immunotherapy
Dominick G. A. Burton et al.
AGEING RESEARCH REVIEWS (2018)
A versatile drug delivery system targeting senescent cells
Daniel Munoz-Espin et al.
EMBO MOLECULAR MEDICINE (2018)
Senolytics improve physical function and increase lifespan in old age
Ming Xu et al.
NATURE MEDICINE (2018)
Two-Step Senescence-Focused Cancer Therapies
Cynthia J. Sieben et al.
TRENDS IN CELL BIOLOGY (2018)
Hallmarks of Cellular Senescence
Alejandra Hernandez-Segura et al.
TRENDS IN CELL BIOLOGY (2018)
Regulatory T cells trigger effector T cell DNA damage and senescence caused by metabolic competition
Xia Liu et al.
NATURE COMMUNICATIONS (2018)
Inhibition of the Stromal p38MAPK/MK2 Pathway Limits Breast Cancer Metastases and Chemotherapy-Induced Bone Loss
Bhavna Murali et al.
CANCER RESEARCH (2018)
Autophagy Governs Protumorigenic Effects of Mitotic Slippage-induced Senescence
Rekha Jakhar et al.
MOLECULAR CANCER RESEARCH (2018)
The Senescence-Stemness Alliance - A Cancer-Hijacked Regeneration Principle
Maja Milanovic et al.
TRENDS IN CELL BIOLOGY (2018)
Fisetin is a senotherapeutic that extends health and lifespan
Matthew J. Yousefzadeh et al.
EBIOMEDICINE (2018)
Senolytic Cocktail Dasatinib+Quercetin (D+Q) Does Not Enhance the Efficacy of Senescence-Inducing Chemotherapy in Liver Cancer
Kristina Kovacovicova et al.
FRONTIERS IN ONCOLOGY (2018)
Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma
Xiaoguang Li et al.
GUT (2017)
Cellular Senescence Promotes Adverse Effects of Chemotherapy and Cancer Relapse
Marco Demaria et al.
CANCER DISCOVERY (2017)
Bafilomycin A1 triggers proliferative potential of senescent cancer cells in vitro and in NOD/SCID mice
Halina Was et al.
ONCOTARGET (2017)
Identification of senescent cell surface targetable protein DPP4
Kyoung Mi Kim et al.
GENES & DEVELOPMENT (2017)
The senescence-associated secretory phenotype induces cellular plasticity and tissue regeneration
Birgit Ritschka et al.
GENES & DEVELOPMENT (2017)
The Clinical Potential of Senolytic Drugs
James L. Kirkland et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2017)
EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
Tsukasa Shibue et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Senescent tumor cells lead the collective invasion in thyroid cancer
Young Hwa Kim et al.
NATURE COMMUNICATIONS (2017)
Small extracellular vesicles secreted from senescent cells promote cancer cell proliferation through EphA2
Masaki Takasugi et al.
NATURE COMMUNICATIONS (2017)
Identification of HSP90 inhibitors as a novel class of senolytics
Heike Fuhrmann-Stroissnigg et al.
NATURE COMMUNICATIONS (2017)
High-Throughput Functional Genetic and Compound Screens Identify Targets for Senescence Induction in Cancer
Liqin Wang et al.
CELL REPORTS (2017)
Clearance of senescent decidual cells by uterine natural killer cells in cycling human endometrium
Paul J. Brighton et al.
ELIFE (2017)
A Novel Indication for Panobinostat as a Senolytic Drug in NSCLC and HNSCC
Leleesha Samaraweera et al.
SCIENTIFIC REPORTS (2017)
Analysis of individual cells identifies cell-to-cell variability following induction of cellular senescence
Christopher D. Wiley et al.
AGING CELL (2017)
Unmasking Transcriptional Heterogeneity in Senescent Cells
Alejandra Hernandez-Segura et al.
CURRENT BIOLOGY (2017)
Senescence-associated IL-6 and IL-8 cytokines induce a self- and cross-reinforced senescence/inflammatory milieu strengthening tumorigenic capabilities in the MCF-7 breast cancer cell line
Paola Ortiz-Montero et al.
CELL COMMUNICATION AND SIGNALING (2017)
Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging
Marjolein P. Baar et al.
CELL (2017)
Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice
Jianhui Chang et al.
NATURE MEDICINE (2016)
Identification of a novel senolytic agent, navitoclax, targeting the Bcl-2 family of anti-apoptotic factors
Yi Zhu et al.
AGING CELL (2016)
Distinct Functions of Senescence-Associated Immune Responses in Liver Tumor Surveillance and Tumor Progression
Tobias Eggert et al.
CANCER CELL (2016)
Therapy-Induced Cellular Senescence Induces Epithelial-to-Mesenchymal Transition and Increases Invasiveness in Rectal Cancer
Joana Tato-Costa et al.
CLINICAL COLORECTAL CANCER (2016)
The CXCL8-CXCR1/2 pathways in cancer
Qian Liu et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2016)
Stromal senescence establishes an immunosuppressive microenvironment that drives tumorigenesis
Megan K. Ruhland et al.
NATURE COMMUNICATIONS (2016)
From Krebs to clinic: glutamine metabolism to cancer therapy
Brian J. Altman et al.
NATURE REVIEWS CANCER (2016)
The Achilles' heel of senescent cells: from transcriptome to senolytic drugs
Yi Zhu et al.
AGING CELL (2015)
The senescent microenvironment promotes the emergence of heterogeneous cancer stem-like cells
Luis Jaime Castro-Vega et al.
CARCINOGENESIS (2015)
FDA Approval: Siltuximab for the Treatment of Patients with Multicentric Castleman Disease
Albert Deisseroth et al.
CLINICAL CANCER RESEARCH (2015)
mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype
Nicolas Herranz et al.
NATURE CELL BIOLOGY (2015)
MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation
Remi-Martin Laberge et al.
NATURE CELL BIOLOGY (2015)
CCL5/CCR5 axis induces vascular endothelial growth factor-mediated tumor angiogenesis in human osteosarcoma microenvironment
Shih-Wei Wang et al.
CARCINOGENESIS (2015)
IL-6 enriched lung cancer stem-like cell population by inhibition of cell cycle regulators via DNMT1 upregulation
Chen-Chi Liu et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Transforming growth factor-β1-induced epithelial-mesenchymal transition generates ALDH-positive cells with stem cell properties in cholangiocarcinoma
Ze-Yu Shuang et al.
CANCER LETTERS (2014)
An Essential Role for Senescent Cells in Optimal Wound Healing through Secretion of PDGF-AA
Marco Demaria et al.
DEVELOPMENTAL CELL (2014)
TLR8 signaling enhances tumor immunity by preventing tumor-induced T-cell senescence
Jian Ye et al.
EMBO MOLECULAR MEDICINE (2014)
Interleukin-6-induced epithelial-mesenchymal transition through signal transducer and activator of transcription 3 in human cervical carcinoma
Jin-Wei Miao et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
Chronic Inflammation (Inflammaging) and Its Potential Contribution to Age-Associated Diseases
Claudio Franceschi et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2014)
Cellular senescence: from physiology to pathology
Daniel Munoz-Espin et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
The Inflammatory Chemokine CCL5 and Cancer Progression
Donatella Aldinucci et al.
MEDIATORS OF INFLAMMATION (2014)
Eotaxin-1 promotes prostate cancer cell invasion via activation of the CCR3-ERK pathway and upregulation of MMP-3 expression
Feng Zhu et al.
ONCOLOGY REPORTS (2014)
The two faces of IL-6 in the tumor microenvironment
Daniel T. Fisher et al.
SEMINARS IN IMMUNOLOGY (2014)
Enhancing Chemotherapy Efficacy in Pten-Deficient Prostate Tumors by Activating the Senescence-Associated Antitumor Immunity
Alberto Toso et al.
CELL REPORTS (2014)
Programmed Cell Senescence during Mammalian Embryonic Development
Daniel Munoz-Espin et al.
CELL (2013)
Senescence Is a Developmental Mechanism that Contributes to Embryonic Growth and Patterning
Mekayla Storer et al.
CELL (2013)
Role of the IL-6-JAK1-STAT3-Oct-4 pathway in the conversion of non-stem cancer cells into cancer stem-like cells
Seog-Young Kim et al.
CELLULAR SIGNALLING (2013)
Synthetic lethal metabolic targeting of cellular senescence in cancer therapy
Jan R. Doerr et al.
NATURE (2013)
A complex secretory program orchestrated by the inflammasome controls paracrine senescence
Juan Carlos Acosta et al.
NATURE CELL BIOLOGY (2013)
p53-Mediated Senescence Impairs the Apoptotic Response to Chemotherapy and Clinical Outcome in Breast Cancer
James G. Jackson et al.
CANCER CELL (2012)
SASP mediates chemoresistance and tumor-initiating-activity of mesothelioma cells
C. Canino et al.
ONCOGENE (2012)
Senescence: a new weapon for cancer therapy
Juan Carlos Acosta et al.
TRENDS IN CELL BIOLOGY (2012)
Senescence-associated secretory phenotype favors the emergence of cancer stem-like cells
J. Cahu et al.
CELL DEATH & DISEASE (2012)
Regulation of Cancer Stem Cells by Cytokine Networks: Attacking Cancer's Inflammatory Roots
Hasan Korkaya et al.
CLINICAL CANCER RESEARCH (2011)
p38MAPK is a novel DNA damage response-independent regulator of the senescence-associated secretory phenotype
Adam Freund et al.
EMBO JOURNAL (2011)
Control of the senescence-associated secretory phenotype by NF-κB promotes senescence and enhances chemosensitivity
Yuchen Chien et al.
GENES & DEVELOPMENT (2011)
Drug-induced Senescence Generates Chemoresistant Stemlike Cells with Low Reactive Oxygen Species
Santhi Achuthan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Senescence surveillance of pre-malignant hepatocytes limits liver cancer development
Tae-Won Kang et al.
NATURE (2011)
Transcription factors that mediate epithelial-mesenchymal transition lead to multidrug resistance by upregulating ABC transporters
M. Saxena et al.
CELL DEATH & DISEASE (2011)
The Senescence-Associated Secretory Phenotype: The Dark Side of Tumor Suppression
Jean -Philippe Coppe et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2010)
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
Kai Kessenbrock et al.
CELL (2010)
CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts
Christophe Ginestier et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
A Human-Like Senescence-Associated Secretory Phenotype Is Conserved in Mouse Cells Dependent on Physiological Oxygen
Jean-Philippe Coppe et al.
PLOS ONE (2010)
CCL5 increases lung cancer migration via PI3K Akt and NF-kappa B pathways
Chun-Yin Huang et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Cancer stem cells and escape from drug-induced premature senescence in human lung tumor cells Implications for drug resistance and in vitro drug screening models
Michal Sabisz et al.
CELL CYCLE (2009)
Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion
Francis Rodier et al.
NATURE CELL BIOLOGY (2009)
STATs in cancer inflammation and immunity: a leading role for STAT3
Hua Yu et al.
NATURE REVIEWS CANCER (2009)
IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial
P. Emery et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
The epithelial-mesenchymal transition generates cells with properties of stem cells
Sendurai A. Mani et al.
CELL (2008)
Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network
Thomas Kuilman et al.
CELL (2008)
Chemokine signaling via the CXCR2 receptor reinforces senescence
Juan C. Acosta et al.
CELL (2008)
The Interleukin-8 Pathway in Cancer
David J. J. Waugh et al.
CLINICAL CANCER RESEARCH (2008)
Cancer-related inflammation
Alberto Mantovani et al.
NATURE (2008)
Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor
Jean-Philippe Coppe et al.
PLOS BIOLOGY (2008)
Senescent human fibroblasts increase the early growth of xenograft tumors via matrix metalloproteinase secretion
Dan Liu et al.
CANCER RESEARCH (2007)
Secretion of vascular endothelial growth factor by primary human fibroblasts at senescence
Jean-Philippe Coppe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Escape from therapy-induced accelerated cellular senescence in p53-null lung cancer cells and in human lung cancers
RS Roberson et al.
CANCER RESEARCH (2005)
Evasion of a single-step, chemotherapy-induced senescence in breast cancer cells: Implications for treatment response
LW Elmore et al.
CLINICAL CANCER RESEARCH (2005)
分享论文
